Metabolic models predict fotemustine and the combination of eflornithine/rifamycin and adapalene/cannabidiol for the treatment of gliomas. - Ali Kishk; Maria Pires Pacheco; Tony Heurtaux; Thomas Sauter (Briefings Bioinform., 2024)